Jushi Holdings (JUSHF) Capital Expenditures Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | -21.54% |
| 10 | Jushi Holdings | 81.50 Mn | 41.80 Mn | 29.88 Mn | -24.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.12% |
| Dec 31, 2025 | -203.58% |
| Sep 30, 2025 | -85.71% |
| Jun 30, 2025 | -28.02% |
| Mar 31, 2025 | 108.31% |
| Dec 31, 2024 | -84.61% |
| Sep 30, 2024 | -87.22% |
| Jun 30, 2024 | 269.59% |
| Mar 31, 2024 | -63.94% |
| Dec 31, 2023 | 172.51% |
| Sep 30, 2023 | 61.96% |
| Jun 30, 2023 | 97.46% |
| Mar 31, 2023 | -88.76% |
| Dec 31, 2022 | 91.37% |
| Sep 30, 2022 | -73.05% |